Skip to main content
Scienza Health
PAC/LTC

Substance Abuse Screening in PAC with GIA®

David Kaiser, Founder & CEO··Updated April 2026·3 min read
Share

Substance abuse can significantly impede the recovery process in Post-Acute Care (PAC) settings. [GIA®](/gia), integrated with [digitalhumanOS™](/platform), offers a discreet and effective method for substance abuse [screening](/gia).

Last updated: April 2026

Key Facts

  • Substance abuse can hinder recovery in PAC.
  • Early intervention improves treatment success.
  • GIA® facilitates discreet substance abuse screening.

Substance abuse can significantly impede the recovery process in Post-Acute Care (PAC) settings. GIA®, integrated with digitalhumanOS™, offers a discreet and effective method for substance abuse screening. Early intervention is crucial for improving treatment outcomes and supporting patients on their path to recovery.

PAC Challenges

Substance abuse can complicate rehabilitation and increase the risk of complications in PAC.

GIA®'s Solution

GIA® provides a non-judgmental and confidential screening process via digitalhumanOS™.

Streamlined Process

Integrates seamlessly into existing PAC workflows, minimizing disruption to patient care.

Improved Outcomes

Early intervention can lead to better treatment adherence and improved recovery outcomes.

Conclusion

Utilizing GIA® for substance abuse screening in PAC enables case managers to provide comprehensive and supportive care, promoting successful recovery and preventing relapse.

Sources & References

  1. Behavioral Health Assessment Using Vocal Biomarkers. 2026.
  2. Audio-based Detection of Anxiety and Depression via Vocal Biomarkers. 2023.
  3. Scienza Health internal validation: 35+ conditions screened, 2,500+ speech biomarkers.
DK
David KaiserFounder & CEO

David Kaiser is the Founder and CEO of Scienza Health, the company behind Gia, an AI co-clinician that health plans, ACOs, health systems and senior-care operators use to check in with older adults between visits.

This content is intended for informational purposes and does not constitute medical advice. Citing research does not mean this page or the product has been independently peer reviewed.

Frequently Asked Questions

Is it confidential?

Strictly confidential, HIPAA compliant.

Is it easy to administer?

User-friendly and efficient.

What happens after screening?

Referral to appropriate resources.

Share

See Gia work on your population.

Predictive medicine, from home care to health systems.

Book a demo